Compound Detail
CHEMBL5089324
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
CC(C)(C)c1ccc(N(C(=O)C(=O)C(F)(F)F)C(C(=O)NC2CCCCC2)c2cccnc2)cc1
Basic Information
| ChEMBL ID | CHEMBL5089324 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | UPYWGWPXHKDUIP-UHFFFAOYSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names
Molecular Properties
489.5
MW (Da)
5.03
ALogP
4
HBA
1
HBD
79.4
PSA (Ų)
0.58
QED
1
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 4.91
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Unchecked CHEMBL612545 | IC50 | 4.91 | 4.91 | 12400.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Unchecked | IC50 | = | 12400.0 | nM | 4.91 | Inhibition of SARS-CoV-2 3CL protease using DABCYL-KTSAVLQ-SGFRKME-EDANS as subs... | 34995923 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 34995923 | 10.1016/j.ejmech.2021.114046 | Unchecked | 2 |
Data from ChEMBL 36 via Core Engine